Breaking News Instant updates and real-time market news.

2020-04-22 10:04:15 XYL Xylem $69.80 / +1.5 (+2.20%) 10:04 04/22/20 04/22 10:04 04/22/20 10:04	Xylem partners with Americares for COVID-19 response, global health network Xylem Watermark announced it is partnering with Americares to combat the spread of COVID-19. The new global partnership will deliver much-needed personal protective equipment, water and sanitation infrastructure repairs and WASH education to frontline healthcare facilities around the world. Xylem Watermark is providing new funding to Americares, the majority of which is dedicated to the Americares COVID-19 response efforts. As the health-focused organization's first water technology partner, Xylem Watermark will support sustained programming for the next five years. With Xylem Watermark's support, Americares will deliver 50,000 protective supplies -- such as masks, gloves, gowns and disinfectants to health care facilities in under-resourced communities in the U.S. and around the world, and train approximately 2,500 health workers. The trainings will focus on infection prevention and control, including water, sanitation and hygiene best practices to control the spread of COVID-19. Xylem employees will participate by volunteering remotely with the Americares emergency response team, developing a COVID-19 training module to help health workers halt the spread of the disease and prevent future outbreaks. Longer term, Americares and Xylem will partner on water and sanitation infrastructure improvements at select health facilities hard hit by the pandemic to respond to long-term water and sanitation issues and build resilience against future outbreaks. Xylem Watermark's support for Americares COVID-19 response is part of a broader, long-term commitment that aims to improve the health of low-income families around the world through improved education and infrastructure. Over the next five years, Xylem water and sanitation experts will work closely with the Americares technical experts to incorporate water and sanitation education and infrastructure improvements into disaster response activities and ongoing health programs. Xylem's five-year partnership funding will also contribute to achieving the Company's 2025 sustainability goals, including disaster-response commitments. Financial terms of the partnership were not disclosed.	05 May 13 May
XYL Xylem $69.80 / +1.5 (+2.20%) 04/16/20 Vertical Research Xylem downgraded to Sell from Hold at Vertical Research 04/08/20 Goldman Sachs Xylem downgraded to Sell from Neutral at Goldman Sachs 03/31/20 Atlantic Equities Xylem downgraded to Neutral from Overweight at Atlantic Equities 03/27/20 Oppenheimer Xylem downgraded to Perform from Outperform at Oppenheimer

2020-04-22 10:04:15

XYL

Xylem

$69.80 / +1.5 (+2.20%)

10:04

04/22/20

04/22

10:04

04/22/20

10:04

Xylem partners with Americares for COVID-19 response, global health network

Xylem Watermark announced it is partnering with Americares to combat the spread of COVID-19. The new global partnership will deliver much-needed personal protective equipment, water and sanitation infrastructure repairs and WASH education to frontline healthcare facilities around the world. Xylem Watermark is providing new funding to Americares, the majority of which is dedicated to the Americares COVID-19 response efforts. As the health-focused organization's first water technology partner, Xylem Watermark will support sustained programming for the next five years. With Xylem Watermark's support, Americares will deliver 50,000 protective supplies -- such as masks, gloves, gowns and disinfectants to health care facilities in under-resourced communities in the U.S. and around the world, and train approximately 2,500 health workers. The trainings will focus on infection prevention and control, including water, sanitation and hygiene best practices to control the spread of COVID-19. Xylem employees will participate by volunteering remotely with the Americares emergency response team, developing a COVID-19 training module to help health workers halt the spread of the disease and prevent future outbreaks. Longer term, Americares and Xylem will partner on water and sanitation infrastructure improvements at select health facilities hard hit by the pandemic to respond to long-term water and sanitation issues and build resilience against future outbreaks. Xylem Watermark's support for Americares COVID-19 response is part of a broader, long-term commitment that aims to improve the health of low-income families around the world through improved education and infrastructure. Over the next five years, Xylem water and sanitation experts will work closely with the Americares technical experts to incorporate water and sanitation education and infrastructure improvements into disaster response activities and ongoing health programs. Xylem's five-year partnership funding will also contribute to achieving the Company's 2025 sustainability goals, including disaster-response commitments. Financial terms of the partnership were not disclosed.

05
May
13
May

XYL Xylem

$69.80 / +1.5 (+2.20%)

04/16/20 Vertical Research: Xylem downgraded to Sell from Hold at Vertical Research

04/08/20 Goldman Sachs: Xylem downgraded to Sell from Neutral at Goldman Sachs

03/31/20 Atlantic Equities: Xylem downgraded to Neutral from Overweight at Atlantic Equities

03/27/20 Oppenheimer: Xylem downgraded to Perform from Outperform at Oppenheimer

TODAY'S FREE FLY STORIES

Hot Stocks	SSR Mining names Alison White as CFO » 18:56 02/26/21 02/26 18:56 02/26/21 18:56 SSRM SSR Mining $14.19 / -0.66 (-4.44%) , NEM Newmont $54.37 / -1.74 (-3.10%) SSR Mining (SSRM)… SSR Mining (SSRM) announced the appointment of Alison White as Executive Vice President and CFO. Prior to joining SSR Mining, White held various corporate and regional roles at Newmont Mining (NEM) including serving as the Regional CFO for North America. White will join the company at the end of March. ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options SSRM NEM SSRM SSR Mining $14.19 / -0.66 (-4.44%) 02/17/21 SSR Mining sees FY21 production 720K-800K gold equivalent oz. 01/19/21 SSR Mining sees FY21 gold production 720K-800K equivalent ounces 11/25/20 SSR Mining reports 'positive results' from drilling program at C2 target 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 NEM Newmont $54.37 / -1.74 (-3.10%) 02/18/21 Newmont sees FY21 gold production 6.5M ounces 02/17/21 Newmont increases quarterly dividend by 38% to 55c per share 01/14/21 Newmont announces up to $1B share repurchase program 12/20/20 Fly Intel: Top five weekend stock stories SSRM NEM SSRM SSR Mining $14.19 / -0.66 (-4.44%) 02/18/21 Canaccord SSR Mining price target lowered to C$26 from C$35 at Canaccord 02/10/21 JPMorgan SSR Mining initiated with an Overweight at JPMorgan 02/02/21 National Bank SSR Mining price target lowered to C$39 from C$41 at National Bank 01/11/21 National Bank SSR Mining price target lowered to C$41 from C$45 at National Bank NEM Newmont $54.37 / -1.74 (-3.10%) 02/19/21 Citi Newmont price target lowered to $66 from $70 at Citi 02/10/21 JPMorgan Newmont assumed with an Overweight at JPMorgan 02/02/21 National Bank Newmont price target lowered to C$109 from C$111 at National Bank 01/11/21 National Bank Newmont price target lowered to C$111 from C$122 at National Bank SSRM NEM SSRM SSR Mining $14.19 / -0.66 (-4.44%) 02/17/21 SSR Mining reports Q4 adjusted EPS 50c, consensus 0c 11/12/20 SSR Mining reports Q3 adjusted EPS 49c, consensus 0c NEM Newmont $54.37 / -1.74 (-3.10%) 02/18/21 Newmont reports Q4 EPS $1.02, consensus 95c 10/29/20 Newmont reports Q3 EPS 86c, consensus 85c NEM NEM Newmont $54.37 / -1.74 (-3.10%) 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 10/15/20 Newmont CEO not interested in Rio Tinto chief job, FT reports SSRM NEM SSRM SSR Mining $14.19 / -0.66 (-4.44%) 10/26/20 Largest borrow rate increases among liquid names 09/14/20 Largest borrow rate increases among liquid names NEM Newmont $54.37 / -1.74 (-3.10%) 01/29/21 Newmont Mining call volume above normal and directionally bullish 01/04/21 Newmont Mining call volume above normal and directionally bullish 12/17/20 Unusually active option classes on open December 17th 12/07/20 Early notable gainers among liquid option names on December 7th
Hot Stocks	Arista Networks CEO: Our growth is back » 18:25 02/26/21 02/26 18:25 02/26/21 18:25 ANET Arista Networks $279.85 / -0.42 (-0.15%) In an interview on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ANET Arista Networks $279.85 / -0.42 (-0.15%) 11/03/20 Arista Networks rises 17.3% 11/03/20 Arista Networks rises 12.0% 11/02/20 Arista Networks jumps 10% to $237 after Q3 earnings beat 11/02/20 Arista Networks CFO says saw continued improvement in business trends ANET Arista Networks $279.85 / -0.42 (-0.15%) 02/19/21 JPMorgan Arista Networks price target raised to $365 from $350 at JPMorgan 02/19/21 Jefferies Arista Networks price target raised to $295 from $240 at Jefferies 02/19/21 Cowen Arista Networks price target raised to $365 from $272 at Cowen 02/19/21 Wells Fargo Arista Networks price target raised to $340 from $240 at Wells Fargo ANET Arista Networks $279.85 / -0.42 (-0.15%) 02/18/21 Arista Networks sees Q1 revenue $630M-$650M, consensus $610.4M 02/18/21 Arista Networks reports Q4 EPS $2.49, consensus $2.39 11/02/20 Arista Networks sees Q4 revenue $615M-$635M, consensus $609.26M. 11/02/20 Notable companies reporting after market close ANET Arista Networks $279.85 / -0.42 (-0.15%) 02/18/21 Fly Intel: After-Hours Movers 11/03/20 Fly Intel: Wall Street's top stories for Tuesday 11/03/20 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: After-Hours Movers
Hot Stocks	Estee Lauder's Haney sells 8,000 class A common shares » 18:04 02/26/21 02/26 18:04 02/26/21 18:04 EL Estee Lauder $286.00 / -3.7 (-1.28%) In a regulatory filing,… In a regulatory filing, Estee Lauder executive VP of Global R&D Carl P. Haney disclosed the sale of 8,000 class A common shares of the company on February 24 at a price of $295.49 per share. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/23/21 Estee Lauder to increase ownership in DECIEM Beauty Group from 29% to 76% 02/05/21 Estee Lauder CEO: We have a great strategy and it's working 02/05/21 Estee Lauder not providing EPS, sales guidance for FY21 02/05/21 Estee Lauder plans to resume share repurchases in 2H21 EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/24/21 DA Davidson Estee Lauder price target raised to $348 from $320 at DA Davidson 02/24/21 Deutsche Bank Estee Lauder price target raised to $316 from $307 at Deutsche Bank 02/22/21 Morgan Stanley Estee Lauder price target raised to $331 from $312 at Morgan Stanley 02/09/21 RBC Capital Estee Lauder price target raised to $314 from $271 at RBC Capital EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/05/21 Estee Lauder reports Q2 adjusted EPS $2.61, consensus $1.69 02/05/21 Estee Lauder sees Q3 adjusted EPS $1.10-$1.20, consensus $1.46 02/05/21 Estee Lauder reports Q2 diluted EPS $2.37, consensus $1.69 02/04/21 Notable companies reporting before tomorrow's open EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/24/21 Estee Lauder to close down Becca brand, WWD reports EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/08/21 Estee Lauder rises as analysts say buy on strong quarter, pivot to digital 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 02/05/21 Fly Intel: Pre-market Movers 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 05/03/21 Estee Lauder - EL EL Estee Lauder $286.00 / -3.7 (-1.28%) 02/05/21 Early notable gainers among liquid option names on February 5th
Hot Stocks	Solaris Oilfield CEO Zartler sells 500,000 common shares » 17:49 02/26/21 02/26 17:49 02/26/21 17:49 SOI Solaris Oilfield $11.84 / +0.29 (+2.51%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SOI Solaris Oilfield $11.84 / +0.29 (+2.51%) 01/26/21 Solaris Oilfield rises -0.9% 01/26/21 Solaris Oilfield rises 1.5% 01/19/21 Solaris Oilfield sees Q4 silo system count up 20%-25% from Q3 12/02/20 Solaris Oilfield announces collaboration with Amazon Web Services SOI Solaris Oilfield $11.84 / +0.29 (+2.51%) 02/25/21 B. Riley Securities Solaris Oilfield price target raised to $14 from $12.50 at B. Riley Securities 01/25/21 B. Riley Securities Solaris Oilfield price target raised to $12.50 from $11 at B. Riley Securities 12/15/20 Citi Solaris Oilfield price target raised to $9.60 from $7 at Citi 08/13/20 Wells Fargo Solaris Oilfield downgraded to Equal Weight at Wells Fargo SOI Solaris Oilfield $11.84 / +0.29 (+2.51%) 10/29/20 Solaris Oilfield reports Q3 adjusted EPS (9c), consensus (9c) 03/01/21 26th Annual Energy Virtual Summit
Conference/Events	Cowen Internet & restaurants analysts to hold analyst/industry conference call » 17:48 02/26/21 02/26 17:48 02/26/21 17:48 GRUB GrubHub $63.95 / +0.86 (+1.36%) , UBER Uber $51.81 / +0.35 (+0.68%) Internet & New Media… Internet & New Media Analyst Blackledge, Restaurants Analyst Charles and Merger/Event Strategist Glick discuss what is happening and what could happen on an Analyst/Industry conference call to be held on March 5 at 12 pm. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UBER GRUB UBER Uber $51.81 / +0.35 (+0.68%) 10:04 Today EVgo says partnering to offer savings for EV drivers on Uber's platform 02/19/21 Uber to launch 'nationwide consultation' in UK after Supreme Court ruling 02/19/21 Uber drops 3% to $57.10 after U.K. Supreme Court rejects appeal 02/19/21 U.K. Supreme Court rejects Uber appeal, says drivers are workers GRUB GrubHub $63.95 / +0.86 (+1.36%) 02/03/21 GrubHub reports Q4 active diners 31.4M, up 39% 01/14/21 GrubHub names Devry Boughner Vorwerk as Chief Corporate Affairs Officer 01/13/21 GrubHub falls -5.5% 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles GRUB UBER GRUB GrubHub $63.95 / +0.86 (+1.36%) 01/04/21 Barclays GrubHub assumed with an Equal Weight at Barclays 10/16/20 HSBC HSBC upgrades Just Eat Takeaway.com to Buy on continued execution 08/28/20 Piper Sandler Piper 'bearishly inclined' on Uber, Lyft shares into November election 08/13/20 DA Davidson GrubHub price target raised to $79 from $63 at DA Davidson UBER Uber $51.81 / +0.35 (+0.68%) 02/22/21 Loop Capital Airbnb upgraded to Buy from Hold at Loop Capital 02/17/21 Argus Uber price target raised to $73 from $63 at Argus 02/16/21 JMP Securities Uber price target raised to $75 from $58 at JMP Securities 02/12/21 DA Davidson Uber price target raised to $72 from $49 at DA Davidson UBER GRUB UBER Uber $51.81 / +0.35 (+0.68%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/10/21 Uber reports Q4 EPS (54c), consensus (55c) 02/10/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports GRUB GrubHub $63.95 / +0.86 (+1.36%) 02/03/21 GrubHub reports Q4 adjusted EPS (41c), consensus 5c 02/03/21 Notable companies reporting after market close 10/28/20 GrubHub reports Q3 non-GAAP EPS 16c, consensus (9c) 08 Jan UBER GRUB UBER Uber $51.81 / +0.35 (+0.68%) 06:17 Today Uber-backed Lime in early talks to go public via a SPAC, BI reports 02/24/21 China's Didi Chuxing plans to make debut in Western Europe, Bloomberg says 02/18/21 Uber pushes 'work from home policy' out till mid-September, Tech Crunch reports 02/12/21 Uber would consider accepting bitcoin, CEO tells CNBC GRUB GrubHub $63.95 / +0.86 (+1.36%) 10/27/20 Suit claims Grubhub added eateries to platform without consent, Bloomberg says 08/28/20 NYC Council extends fee caps on food delivery apps, NY Post reports UBER GRUB UBER Uber $51.81 / +0.35 (+0.68%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/12/21 The Intersection: Crypto and Wall Street This Week 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday GRUB GrubHub $63.95 / +0.86 (+1.36%) 02/03/21 Fly Intel: After-Hours Movers 09/04/20 Fly Intel: Pre-market Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference UBER UBER Uber $51.81 / +0.35 (+0.68%) 02/25/21 Uber call volume above normal and directionally bullish 02/10/21 Uber options imply 11.7% move in share price post-earnings 01/11/21 Uber call volume above normal and directionally bullish 01/07/21 Uber call volume above normal and directionally bullish

Syndicate	National Storage files automatic mixed securities shelf 17:47 02/26/21 02/26 17:47 02/26/21 17:47 NSA National Storage $38.67 / -1.03 (-2.59%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NSA National Storage $38.67 / -1.03 (-2.59%) 11/12/20 National Storage raises quarterly dividend to 35c per share NSA National Storage $38.67 / -1.03 (-2.59%) 01/08/21 Evercore ISI Evercore ISI starts National Storage at Outperform with $42 price target 01/08/21 Evercore ISI National Storage initiated with an Outperform at Evercore ISI 01/07/21 BMO Capital National Storage upgraded to Outperform from Market Perform at BMO Capital 12/31/20 Truist National Storage price target raised to $36 from $32 at Truist NSA National Storage $38.67 / -1.03 (-2.59%) 02/22/21 National Storage sees FY21 core FFO $1.81-$1.86, consensus $1.78 02/22/21 National Storage reports Q4 core FFO 46c, consensus 43c 11/05/20 National Storage reports Q3 FFO 44c, consensus 41c 23 Sep NSA National Storage $38.67 / -1.03 (-2.59%) 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street 09/23/20 Fly Intel: Pre-market Movers
Hot Stocks	J&J confirms FDA panel recommends COVID-19 vaccine for EUA » 17:45 02/26/21 02/26 17:45 02/26/21 17:45 JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) Johnson & Johnson… Johnson & Johnson announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee unanimously voted to recommend Emergency Use Authorization for the company's single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial. "We are extremely grateful to the VRBPAC members for their extensive review of the data supporting emergency use of Johnson & Johnson's single-shot COVID-19 vaccine candidate," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We believe our COVID-19 vaccine candidate has the potential to help change the trajectory of the pandemic and stand ready to make it available to protect the public as soon as possible." The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate. The recommendation of the FDA Advisory Committee is non-binding, and the final decision on authorization is made by the FDA. Under an EUA, the FDA has the authority to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions during a declared public health emergency. If authorized by the FDA, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will then provide a recommendation on the use and roll-out of the Janssen COVID-19 vaccine candidate. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/24/21 J&J vaccine effective in preventing Covid-19, FDA panel says 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 17:06 Today FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 06:11 Today FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/02/21 41st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd
Syndicate	Invitae files to sell 1.37M shares of common stock for holders 17:43 02/26/21 02/26 17:43 02/26/21 17:43 NVTA Invitae $40.13 / +0.335 (+0.84%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options NVTA Invitae $40.13 / +0.335 (+0.84%) 01/13/21 Pacific Biosciences, Invitae to develop genome sequencing platform 01/11/21 Invitae falls -10.2% 12/17/20 Invitae falls -7.4% 12/17/20 Invitae introduces routine exome reanalysis NVTA Invitae $40.13 / +0.335 (+0.84%) 02/18/21 Ladenburg Invitae upgraded to Buy with $58 price target at Ladenburg 02/18/21 Ladenburg Invitae upgraded to Buy from Neutral at Ladenburg 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform from Outperform at Oppenheimer NVTA Invitae $40.13 / +0.335 (+0.84%) 02/17/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $488.37M 02/17/21 Invitae reports Q4 adjusted EPS (63c), consensus (55c) 01/11/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $513.7M 01/11/21 Invitae reports preliminary FY20 revenue $278M+, consensus $274.93M 22 Jan 02 Apr NVTA Invitae $40.13 / +0.335 (+0.84%) 01/20/21 Fly Intel: After-Hours Movers NVTA Invitae $40.13 / +0.335 (+0.84%) 12/07/20 Invitae call volume above normal and directionally bullish 11/12/20 Invitae call volume above normal and directionally bullish 11/11/20 Invitae call volume above normal and directionally bullish 10/07/20 Invitae call volume above normal and directionally bullish
Syndicate	TravelCenters files $750M mixed securities shelf 17:40 02/26/21 02/26 17:40 02/26/21 17:40 TA TravelCenters $24.15 / -5.125 (-17.51%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TA TravelCenters $24.15 / -5.125 (-17.51%) 02/25/21 TravelCenters enters into agreement to sell QSL business for approx. $5M 02/17/21 TravelCenters signs new franchise agreement for TA Express in California 01/13/21 FleetCor and TravelCenters of America renew Comdata payment acceptance agreement 01/13/21 FleetCor, TravelCenters renew Comdata payment acceptance agreement TA TravelCenters $24.15 / -5.125 (-17.51%) 12/18/20 BMO Capital TravelCenters initiated with an Outperform at BMO Capital 11/16/20 BTIG TravelCenters price target raised to $40 from $34 at BTIG 11/05/20 B. Riley Securities TravelCenters price target raised to $40 from $30 at B. Riley Securities 11/05/20 Citi TravelCenters price target raised to $35 from $29 at Citi TA TravelCenters $24.15 / -5.125 (-17.51%) 02/25/21 TravelCenters reports Q4 EPS (42c) consensus (26c) 11/04/20 TravelCenters reports Q3 EPS 65c, consensus 25c 01 Jul 10:00 Today TravelCenters - TA
Syndicate	Invitae files to sell 28K shares of common stock for holders 17:39 02/26/21 02/26 17:39 02/26/21 17:39 NVTA Invitae $40.13 / +0.335 (+0.84%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options NVTA Invitae $40.13 / +0.335 (+0.84%) 01/13/21 Pacific Biosciences, Invitae to develop genome sequencing platform 01/11/21 Invitae falls -10.2% 12/17/20 Invitae falls -7.4% 12/17/20 Invitae introduces routine exome reanalysis NVTA Invitae $40.13 / +0.335 (+0.84%) 02/18/21 Ladenburg Invitae upgraded to Buy with $58 price target at Ladenburg 02/18/21 Ladenburg Invitae upgraded to Buy from Neutral at Ladenburg 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform from Outperform at Oppenheimer NVTA Invitae $40.13 / +0.335 (+0.84%) 02/17/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $488.37M 02/17/21 Invitae reports Q4 adjusted EPS (63c), consensus (55c) 01/11/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $513.7M 01/11/21 Invitae reports preliminary FY20 revenue $278M+, consensus $274.93M 22 Jan 02 Apr NVTA Invitae $40.13 / +0.335 (+0.84%) 01/20/21 Fly Intel: After-Hours Movers NVTA Invitae $40.13 / +0.335 (+0.84%) 12/07/20 Invitae call volume above normal and directionally bullish 11/12/20 Invitae call volume above normal and directionally bullish 11/11/20 Invitae call volume above normal and directionally bullish 10/07/20 Invitae call volume above normal and directionally bullish

Hot Stocks	Huntington Ingalls awarded up to $213.9M government contract » 17:32 02/26/21 02/26 17:32 02/26/21 17:32 HII Huntington Ingalls $175.91 / -7.34 (-4.01%) Huntington Ingalls… Huntington Ingalls Industries announced that its Ingalls Shipbuilding division has been awarded a cost-plus-fixed-fee contract for life-cycle engineering and support services on the U.S. Navy's San Antonio class of amphibious transport docks. This follow-on contract consists of a base contract valued at $36.9M with a cumulative value of $213.9M if all options are exercised. "This contract enables Ingalls to continue providing LPD support and services that are critical to the sustainment of the Navy's amphibious fleet," Ingalls Shipbuilding President Brian Cuccias said. "Our talented workforce has the knowledge and experience required to perform this important work, and we are committed to ensuring these state-of-the-art warships serve our nation well into the future." Services provided in this contract include engineering change management; systems engineering and integration; supply chain management; training for new LPD 17-class shipboard systems; and the execution of industrial post-delivery availabilities. ShowHide Related Items >><< Company News Street Research Earnings Events Options HII Huntington Ingalls $175.91 / -7.34 (-4.01%) 02/19/21 Huntington Ingalls awarded $2.99B Navy contract 02/11/21 Huntington Ingalls sees FY21 shipbuilding revenue $8.2B-$8.4B 02/03/21 PMC Capital acquires UniversalPegasus International from Huntington Ingalls 01/15/21 Huntington Ingalls awarded $174.91M Navy contract HII Huntington Ingalls $175.91 / -7.34 (-4.01%) 01/06/21 Vertical Research Huntington Ingalls downgraded to Hold from Buy at Vertical Research 12/04/20 Alembic Global Huntington Ingalls upgraded to Overweight from Neutral at Alembic Global 10/02/20 JPMorgan Huntington Ingalls price target lowered to $175 from $205 at JPMorgan 10/01/20 Barclays Huntington Ingalls price target lowered to $160 from $190 at Barclays HII Huntington Ingalls $175.91 / -7.34 (-4.01%) 02/11/21 Huntington Ingalls reports Q4 adjusted EPS $4.35, consensus $4.56 11/05/20 Huntington Ingalls sees 2020 shipbuilding revenue $7.9B 11/05/20 Huntington Ingalls reports Q3 EPS $5.45, consensus $4.13 13:00 Today Aerospace/Defense & Industrial Technology HII Huntington Ingalls $175.91 / -7.34 (-4.01%) 02/11/21 Early notable gainers among liquid option names on February 11th
Hot Stocks	Bell-Boeing awarded $309.58M Navy contract modification » 17:31 02/26/21 02/26 17:31 02/26/21 17:31 BA Boeing $212.02 / -4.435 (-2.05%) Bell-Boeing Joint Project… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $212.02 / -4.435 (-2.05%) 02/24/21 FAA: Pratt & Whitney engines must be inspected before flights resume 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/23/21 Mesa Air signs LOI to lease additional 737-400F cargo aircraft 02/22/21 Boeing recommends suspending operations of 777s powered by Pratt & Whitney BA Boeing $212.02 / -4.435 (-2.05%) 02/19/21 Benchmark Boeing price target lowered to $270 from $290 at Benchmark 02/10/21 Deutsche Bank Airbus initiated with a Buy at Deutsche Bank 01/29/21 Fly Intel: Top five analyst upgrades Spire 01/29/21 Morgan Stanley Morgan Stanley double upgrades Boeing to Overweight after 'kitchen sink' Q4 BA Boeing $212.02 / -4.435 (-2.05%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $212.02 / -4.435 (-2.05%) 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 DOT: FAA must strengthen oversight of aircraft safety, WSJ reports 02/25/21 Boeing had planned to replace 777 engine covers before failures, WSJ reports BA Boeing $212.02 / -4.435 (-2.05%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 01/29/21 Boeing double upgrade among today's top calls on Wall Street 04/20/21 Boeing Co. BA Boeing $212.02 / -4.435 (-2.05%) 02/24/21 Boeing call volume above normal and directionally bullish 02/16/21 Boeing call volume above normal and directionally bullish 01/29/21 Boeing call volume above normal and directionally bullish 12/07/20 Early notable gainers among liquid option names on December 7th
Hot Stocks	Crown Castle CCO Kavanagh sells nearly 4,000 common shares » 17:28 02/26/21 02/26 17:28 02/26/21 17:28 CCI Crown Castle $155.64 / -3.99 (-2.50%) In a regulatory filing,… In a regulatory filing, Crown Castle chief commercial officer Michael Joseph Kavanagh disclosed the sale of 3,796 common shares of the company on February 25 at a price of $161.22 per share. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CCI Crown Castle $155.64 / -3.99 (-2.50%) 12/18/20 Crown Castle releases 2019 corporate sustainability report 11/16/20 Dish signs multiyear anchor tenant tower agreement with Crown Castle 11/09/20 Crown Castle names Chris Levendos as COO - Fiber, effective December 1 10/22/20 Crown Castle increases common stock dividend 11% to $1.33 per share CCI Crown Castle $155.64 / -3.99 (-2.50%) 01/14/21 Citi Crown Castle upgraded to Buy from Neutral at Citi 01/11/21 BofA BofA US 1 List changes 01/04/21 LightShed Partners Crown Castle initiated with a Buy at LightShed Partners 12/11/20 Deutsche Bank Crown Castle upgraded to Buy from Hold at Deutsche Bank CCI Crown Castle $155.64 / -3.99 (-2.50%) 01/27/21 Crown Castle,Verizon expand relationship with long term 5G small cell commitment 01/27/21 Crown Castle backs FY21 AFFO view $6.64-$6.74, consensus $6.70 01/27/21 Crown Castle reports Q4 AFFO $2.33, consensus $1.65 01/27/21 Notable companies reporting after market close CCI Crown Castle $155.64 / -3.99 (-2.50%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says CCI Crown Castle $155.64 / -3.99 (-2.50%) 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades
Hot Stocks	Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic » 17:27 02/26/21 02/26 17:27 02/26/21 17:27 LLY Eli Lilly $204.74 / +0.835 (+0.41%) Eli Lilly was awarded a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $204.74 / +0.835 (+0.41%) 17:22 Today Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 07:02 Today Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. 02/25/21 Eli Lilly, Welldoc announce agreement to create insulin management solution 02/23/21 Veru submits NDA for proprietary TADFIN for BPH LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink LLY Eli Lilly $204.74 / +0.835 (+0.41%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $204.74 / +0.835 (+0.41%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Hot Stocks	Ralph Lauren CCO Smith sells nearly 10,000 class A shares » 17:27 02/26/21 02/26 17:27 02/26/21 17:27 RL Ralph Lauren $117.10 / -0.58 (-0.49%) In a regulatory filing,… In a regulatory filing, Ralph Lauren chief commercial officer Andrew Howard Smith disclosed the sale of 9,763 class A common shares of the company on February 25 at a price of $120 per share. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options RL Ralph Lauren $117.10 / -0.58 (-0.49%) 02/04/21 Ralph Lauren: Foreign tourist sales down 85% in North America in Q3 02/04/21 Ralph Lauren: Second, third wave Covid restrictions more disruptive than first 02/04/21 Ralph Lauren: Global retail environment remained volatile in Q3 due to pandemic 02/04/21 Ralph Lauren: Covid likely to remain a near-term headwind RL Ralph Lauren $117.10 / -0.58 (-0.49%) 02/05/21 Barclays Ralph Lauren price target raised to $109 from $72 at Barclays 02/01/21 Needham Ralph Lauren price target raised to $112 from $82 at Needham 01/26/21 Piper Sandler Ralph Lauren price target raised to $103 from $74 at Piper Sandler 01/21/21 Deutsche Bank Ralph Lauren price target raised to $127 from $75 at Deutsche Bank RL Ralph Lauren $117.10 / -0.58 (-0.49%) 02/04/21 Ralph Lauren sees Q4 revenue down mid-to-high single digits, consensus $1.31B 02/04/21 Ralph Lauren reports Q3 adjusted EPS $1.67, consensus $1.63 02/03/21 Notable companies reporting before tomorrow's open RL Ralph Lauren $117.10 / -0.58 (-0.49%) 01/13/21 Ralph Lauren 'uncooked alert' issued by Betaville blog 09/22/20 Ralph Lauren tells WSJ about 15% of workforce will be cut RL Ralph Lauren $117.10 / -0.58 (-0.49%) 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results RL Ralph Lauren $117.10 / -0.58 (-0.49%) 12/03/20 Early notable gainers among liquid option names on December 3rd 10/02/20 Two week put seller hits the runway in Ralph Lauren

Syndicate	Sorrento Therapeutics files to sell 2.57M shares of common stock for holders 17:26 02/26/21 02/26 17:26 02/26/21 17:26 SRNE Sorrento Therapeutics $9.69 / -0.42 (-4.15%) ShowHide Related Items >><< Company News Street Research On The Fly Options SRNE Sorrento Therapeutics $9.69 / -0.42 (-4.15%) 02/09/21 Lee's Pharmaceutical's socazolimab receives BTD in China 02/08/21 Sorrento subsidiary to develop ADNAB products under license from Mayo Clinic 01/26/21 Sorrento Therapeutics jumps 5% to $11 after positive COVI-MSC study data 01/26/21 Sorrento reports 'positive' preliminary results of Phase 1b COVID-MSC study SRNE Sorrento Therapeutics $9.69 / -0.42 (-4.15%) 01/29/21 B. Riley Securities Sorrento Therapeutics initiated with a Buy at B. Riley Securities 01/21/21 Alliance Global Partners Sorrento Therapeutics initiated with a Buy at Alliance Global Partners 07/31/20 H.C. Wainwright Sorrento Therapeutics price target raised to $30 from $24 at H.C. Wainwright 07/20/20 Dawson James Sorrento antibody cocktail effort could move quickly, says Dawson James SRNE Sorrento Therapeutics $9.69 / -0.42 (-4.15%) 01/19/21 Fly Intel: After-Hours Movers 12/23/20 Fly Intel: Wall Street's top stories for Wednesday 12/23/20 Fly Intel: Wall Street's top stories at midday 11/27/20 Fly Intel: Pre-market Movers SRNE Sorrento Therapeutics $9.69 / -0.42 (-4.15%) 02/08/21 Sorrento Therapeutics call volume above normal and directionally bullish 01/29/21 Sorrento Therapeutics call volume above normal and directionally bullish 01/27/21 Sorrento Therapeutics call volume above normal and directionally bullish 01/26/21 Sorrento Therapeutics call volume above normal and directionally bullish
Syndicate	FireEye files to sell 400K shares of 4.5% of Series A convertible stock 17:23 02/26/21 02/26 17:23 02/26/21 17:23 FEYE FireEye $19.32 / -0.07 (-0.36%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FEYE FireEye $19.32 / -0.07 (-0.36%) 02/03/21 SolarWinds sees 'other additional attack vectors' continuing to come to light 02/02/21 FireEye falls about 4% to $20.89 after Q4 earnings, Q1 and initial FY21 outlook 12/28/20 FireEye director sells 50K shares of common stock 12/11/20 FireEye adds Blackstone senior managing director to board as deal closes FEYE FireEye $19.32 / -0.07 (-0.36%) 02/04/21 Fly Intel: Top five analyst upgrades 02/04/21 BofA FireEye upgraded to Buy on 'solid execution' at BofA 02/04/21 BofA FireEye upgraded to Buy from Neutral at BofA 02/03/21 FireEye price target raised to $25 from $17 at BMO Capital FEYE FireEye $19.32 / -0.07 (-0.36%) 02/02/21 FireEye sees FY21 EPS 35c-37c, consensus 36c 02/02/21 FireEye sees Q1 EPS 5c-7c, consensus 6c 02/02/21 FireEye reports Q4 EPS 12c, consensus 10c 02/02/21 Notable companies reporting after market close FEYE FireEye $19.32 / -0.07 (-0.36%) 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says 01/11/21 FBI investigating Russian-linked postcard sent to FireEye CEO, Reuters reports 12/24/20 Suspected Russian hack on agencies failed to breach CrowdStrike, Reuters reports 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says FEYE FireEye $19.32 / -0.07 (-0.36%) 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 12/08/20 Fly Intel: After-Hours Movers 11/20/20 Fly Intel: Wall Street's top stories for Friday 11/20/20 Fly Intel: Wall Street's top stories at midday FEYE FireEye $19.32 / -0.07 (-0.36%) 02/02/21 FireEye options imply 18.5% move in share price post-earnings 12/28/20 FireEye call volume above normal and directionally bullish 12/24/20 Unusually active option classes on open December 24th 12/18/20 FireEye call volume above normal and directionally bullish
Hot Stocks	Eli Lilly awarded $2.52B Army contract for LY-CoV555, LY-CoV016 » 17:22 02/26/21 02/26 17:22 02/26/21 17:22 LLY Eli Lilly $204.74 / +0.835 (+0.41%) Eli Lilly was awarded a… Eli Lilly was awarded a $2.52B firm-fixed-price contract for Eli Lilly's combination monoclonal antibody therapeutic LY-CoV555 and LY-CoV016. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of November 24. U.S. Army Contracting Command is the contracting activity. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $204.74 / +0.835 (+0.41%) 07:02 Today Eli Lilly: Additional doses of neutralizing antibody therapy purchased by U.S. 02/25/21 Eli Lilly, Welldoc announce agreement to create insulin management solution 02/23/21 Veru submits NDA for proprietary TADFIN for BPH 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink LLY Eli Lilly $204.74 / +0.835 (+0.41%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $204.74 / +0.835 (+0.41%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 03/02/21 41st Annual Healthcare Virtual Conference 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $204.74 / +0.835 (+0.41%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Syndicate	SBA Communications files automatic mixed securities shelf 17:22 02/26/21 02/26 17:22 02/26/21 17:22 SBAC SBA Communications $255.17 / -1.43 (-0.56%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals SBAC SBA Communications $255.17 / -1.43 (-0.56%) 02/22/21 Dish signs master lease agreement with SBA Communications 02/02/21 PG&E unit sells rights to 700 towers to SBA Communications for $973M 01/24/21 Fly Intel: Top five weekend stock stories SBAC SBA Communications $255.17 / -1.43 (-0.56%) 02/23/21 Credit Suisse SBA Communications price target lowered to $277 from $291 at Credit Suisse 02/23/21 Barclays SBA Communications price target raised to $310 from $305 at Barclays 02/23/21 Deutsche Bank SBA Communications price target lowered to $325 from $335 at Deutsche Bank 02/08/21 JPMorgan JPMorgan downgrades SBA to Neutral on 'lukewarm' tower stance SBAC SBA Communications $255.17 / -1.43 (-0.56%) 02/22/21 SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 02/22/21 SBA Communications reports Q4 AFFO $2.49, consensus $2.44 11/02/20 SBA Communications raises FY20 AFFO view to $9.27-$9.50 from $8.94-$9.33 11/02/20 SBA Communications reports Q3 AFFO $2.38, consensus $2.32 SBAC SBA Communications $255.17 / -1.43 (-0.56%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says
Hot Stocks	General Dynamics, ManTech and Northrop Grumman awarded $4.45B AF contract » 17:16 02/26/21 02/26 17:16 02/26/21 17:16 GD General Dynamics $163.44 / -2.83 (-1.70%) , MANT ManTech $78.18 / -1.31 (-1.65%) , NOC Northrop Grumman $291.73 / -7.13 (-2.39%) General Dynamics (GD),… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NOC MANT GD NOC Northrop Grumman $291.73 / -7.13 (-2.39%) 02/10/21 Northrop Grumman gets DARPA contract for air-to-air missile engagement concept 02/03/21 Northrop Grumman awarded $329.89M Navy contract modification 02/01/21 Northrop Grumman completes sale of IT services business for $3.4B 02/01/21 Northrop Grumman announces $2B accelerated share repurchase program MANT ManTech $78.18 / -1.31 (-1.65%) 02/04/21 ManTech offers employees tuition-free access to advanced analytics degree 12/14/20 ManTech completes acquisition of Tapestry Technologies 12/03/20 ManTech wins $273M award from DHS for advanced analytics 11/12/20 ManTech acquires Minerva Engineering, terms not disclosed GD General Dynamics $163.44 / -2.83 (-1.70%) 02/04/21 GDIT offers Microsoft Azure to federal agencies 01/27/21 General Dynamics says continuing to see growth outside of U.S. 01/27/21 General Dynamics says had 'very good cash quarter' 01/27/21 General Dynamics: 'Our defense segments continued to capture significant awards' GD MANT NOC GD General Dynamics $163.44 / -2.83 (-1.70%) 01/29/21 Susquehanna General Dynamics price target raised to $180 from $162 at Susquehanna 11/03/20 Morgan Stanley Morgan Stanley sees attractive buying opportunity in Defense stocks 10/29/20 Credit Suisse General Dynamics price target lowered to $140 from $156 at Credit Suisse 10/02/20 Fly Intel: Top five analyst downgrades MANT ManTech $78.18 / -1.31 (-1.65%) 02/23/21 William Blair William Blair reiterates Outperform on Leidos following quarterly results 02/09/21 Alliance Global Partners ManTech downgraded to Neutral from Buy at Alliance Global Partners 07/30/20 Alliance Global Partners ManTech upgraded to Buy from Neutral at Alliance Global Partners 05/19/20 Fly Intel: Top five analyst upgrades NOC Northrop Grumman $291.73 / -7.13 (-2.39%) 01/29/21 Credit Suisse Northrop Grumman price target lowered to $353 from $377 at Credit Suisse 01/29/21 Susquehanna Northrop Grumman price target lowered to $350 from $380 at Susquehanna 01/07/21 Baird Northrop Grumman downgraded to Neutral from Outperform at Baird 12/09/20 Noble Capital Kratos Defense price target raised to $26 from $23 at Noble Capital NOC MANT GD NOC Northrop Grumman $291.73 / -7.13 (-2.39%) 01/28/21 Northrop Grumman sees FY21 adjusted EPS $23.15-$23.65, consensus $24.19 01/28/21 Northrop Grumman reports Q4 adjusted EPS $6.59, consensus $5.77 10/22/20 Northrop Grumman sees FY21 revenue in low-to-mid $37B range, consensus $37.45B 10/22/20 Northrop Grumman raises FY20 adj. EPS view to $22.25-$22.65 from $22.00-$22.40 MANT ManTech $78.18 / -1.31 (-1.65%) 02/17/21 ManTech sees FY21 adjusted EPS $3.48-$3.60, consensus $3.49 02/17/21 ManTech reports Q4 adjusted EPS 89c, consensus 79c 11/05/20 ManTech sees FY20 EPS $3.24 - $3.28, consensus $3.18 11/05/20 ManTech reports Q3 EPS 73c, consensus 76c GD General Dynamics $163.44 / -2.83 (-1.70%) 01/27/21 General Dynamics sees FY21 EPS $11.00-$11.05, consensus $11.34 01/27/21 General Dynamics reports Q4 EPS $3.49, consensus $3.54 01/26/21 Notable companies reporting before tomorrow's open NOC GD NOC Northrop Grumman $291.73 / -7.13 (-2.39%) 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says GD General Dynamics $163.44 / -2.83 (-1.70%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports NOC MANT GD NOC Northrop Grumman $291.73 / -7.13 (-2.39%) 12/08/20 Fly Intel: Wall Street's top stories for Tuesday MANT ManTech $78.18 / -1.31 (-1.65%) 02/17/21 Fly Intel: After-Hours Movers GD General Dynamics $163.44 / -2.83 (-1.70%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks 09/17/20 CVS initiation, Stitch Fix upgrade among today's top calls on Wall Street 13:00 Today Aerospace/Defense & Industrial Technology

Syndicate	PG&E files to sell 477.74M shares of common stock for holders 17:11 02/26/21 02/26 17:11 02/26/21 17:11 PCG PG&E $10.53 / -0.355 (-3.26%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options PCG PG&E $10.53 / -0.355 (-3.26%) 05:40 Today PG&E responds to draft resolution released by CPUC 02/23/21 PG&E appoints Marlene Santos EVP, Chief Customer Officer 02/16/21 Soros buys Ally Financial, exits DraftKings in Q4 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 PCG PG&E $10.53 / -0.355 (-3.26%) 02/12/21 Mizuho PG&E price target raised to $15 from $14 at Mizuho 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo PG&E downgraded to Underweight from Equal Weight at Wells Fargo 11/18/20 Barclays PG&E price target raised to $14 from $13 at Barclays PCG PG&E $10.53 / -0.355 (-3.26%) 02/25/21 PG&E reports Q4 EPS 21c, consensus 23c 10/29/20 PG&E sees FY21 core EPS 95c-$1.05, consensus $1.20 10/29/20 PG&E sees FY20 core EPS $1.60-$1.63, consensus $1.78 10/29/20 PG&E reports Q3 adjusted EPS 22c, consensus 26c 26 Jun PCG PG&E $10.53 / -0.355 (-3.26%) 10/12/20 Judge orders PG&E to explain 'role in the ignition' of Zogg Fire, Bloomberg says 10/11/20 PG&E may cut power this week as CA fire risk returns, Bloomberg reports 09/28/20 PG&E says no indications lines started recent fires, Bloomberg reports PCG PG&E $10.53 / -0.355 (-3.26%) 10/12/20 Fly Intel: Pre-market Movers PCG PG&E $10.53 / -0.355 (-3.26%) 02/18/21 PG&E call volume above normal and directionally bullish 01/15/21 PG&E call volume above normal and directionally bullish 01/15/21 Early notable gainers among liquid option names on January 15th 11/18/20 Early notable gainers among liquid option names on November 18th
Syndicate	PG&E files automatic mixed securities shelf 17:10 02/26/21 02/26 17:10 02/26/21 17:10 PCG PG&E $10.53 / -0.355 (-3.26%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options PCG PG&E $10.53 / -0.355 (-3.26%) 05:40 Today PG&E responds to draft resolution released by CPUC 02/23/21 PG&E appoints Marlene Santos EVP, Chief Customer Officer 02/16/21 Soros buys Ally Financial, exits DraftKings in Q4 02/16/21 Appaloosa buys Macy's and Kohl's, exits AT&T in Q4 PCG PG&E $10.53 / -0.355 (-3.26%) 02/12/21 Mizuho PG&E price target raised to $15 from $14 at Mizuho 01/06/21 Wells Fargo Wells Fargo says buy CenterPoint Energy, sell FirstEnergy 01/06/21 Wells Fargo PG&E downgraded to Underweight from Equal Weight at Wells Fargo 11/18/20 Barclays PG&E price target raised to $14 from $13 at Barclays PCG PG&E $10.53 / -0.355 (-3.26%) 02/25/21 PG&E reports Q4 EPS 21c, consensus 23c 10/29/20 PG&E sees FY21 core EPS 95c-$1.05, consensus $1.20 10/29/20 PG&E sees FY20 core EPS $1.60-$1.63, consensus $1.78 10/29/20 PG&E reports Q3 adjusted EPS 22c, consensus 26c 26 Jun PCG PG&E $10.53 / -0.355 (-3.26%) 10/12/20 Judge orders PG&E to explain 'role in the ignition' of Zogg Fire, Bloomberg says 10/11/20 PG&E may cut power this week as CA fire risk returns, Bloomberg reports 09/28/20 PG&E says no indications lines started recent fires, Bloomberg reports PCG PG&E $10.53 / -0.355 (-3.26%) 10/12/20 Fly Intel: Pre-market Movers PCG PG&E $10.53 / -0.355 (-3.26%) 02/18/21 PG&E call volume above normal and directionally bullish 01/15/21 PG&E call volume above normal and directionally bullish 01/15/21 Early notable gainers among liquid option names on January 15th 11/18/20 Early notable gainers among liquid option names on November 18th
Syndicate	HSBC files automatic mixed securities shelf 17:07 02/26/21 02/26 17:07 02/26/21 17:07 HSBC HSBC $29.72 / -0.45 (-1.49%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HSBC HSBC $29.72 / -0.45 (-1.49%) 01/15/21 Chubb CFO Philip Bancroft to retire, Peter Enns to succeed 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 11/29/20 Fly Intel: Top five weekend stock stories HSBC HSBC $29.72 / -0.45 (-1.49%) 05:28 Today AlphaValue HSBC upgraded to Reduce from Add at AlphaValue 05:26 Today Societe Generale HSBC upgraded to Hold from Sell at Societe Generale 02/25/21 Berenberg HSBC price target raised to 400 GBp from 380 GBp at Berenberg 02/24/21 Barclays HSBC price target raised to 440 GBp from 400 GBp at Barclays HSBC HSBC $29.72 / -0.45 (-1.49%) 10/27/20 HSBC reports Q3 EPS 7c vs. 15c last year HSBC HSBC $29.72 / -0.45 (-1.49%) 02/19/21 HSBC doesn't have to hand over documents to Huawei CFO, WSJ reports 01/27/21 U.K. taps HSBC, JPMorgan to advise on first 'green' bond, Reuters says 01/10/21 HSBC to face shareholder heat on fossil fuels in AGM vote, Reuters says 11/29/20 HSBC considers exit from U.S. retail banking, FT reports HSBC HSBC $29.72 / -0.45 (-1.49%) 10/16/20 The Intersection: Crypto and Wall Street This Week 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 09/21/20 Fly Intel: Pre-market Movers HSBC HSBC $29.72 / -0.45 (-1.49%) 01/07/21 HSBC call volume above normal and directionally bullish 12/09/20 Unusually active option classes on open December 9th 12/04/20 Unusually active option classes on open December 4th 11/09/20 HSBC call volume above normal and directionally bullish
Periodicals	FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says » 17:06 02/26/21 02/26 17:06 02/26/21 17:06 JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) , SPX S&P 500 $0.00 / + (+0.00%) , SPY SPDR S&P 500 ETF Trust $380.35 / -2.04 (-0.53%) An FDA advisory panel has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options Technical Analysis SPY SPX JNJ SPY SPDR S&P 500 ETF Trust $380.35 / -2.04 (-0.53%) 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 SPX S&P 500 $0.00 / + (+0.00%) 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 FDA staff sees 'no specific safety concerns' to preclude EUA for J&J vaccine 02/24/21 J&J vaccine effective in preventing Covid-19, FDA panel says 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony JNJ SPX SPY JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' SPX S&P 500 $0.00 / + (+0.00%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust $380.35 / -2.04 (-0.53%) SPX JNJ SPX S&P 500 $0.00 / + (+0.00%) 02/23/21 S&P 500 targets FY21 EPS 3.00 to $3.20, consensus JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open SPX JNJ SPX S&P 500 $0.00 / + (+0.00%) 14:58 Today House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says 02/10/21 Germany extending virus lockdown until March 7, AP reports 02/08/21 Gove says Britain, EU need reset after Northern Ireland threat, Reuters says JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 06:11 Today FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says 02/24/21 FDA to release detailed review of J&J's Covid vaccine, WSJ reports 02/16/21 South Africa to share AstraZeneca COVID-19 vaccine doses, Reuters reports JNJ JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday 02/05/21 Fly Intel: Wall Street's top stories for Friday 02/05/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/02/21 41st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ SPY SPX JNJ SPY SPDR S&P 500 ETF Trust $380.35 / -2.04 (-0.53%) 11/09/20 Options markets on track for record option volume SPX S&P 500 $0.00 / + (+0.00%) 09:18 Today Overnight activity included 2517 trades in SPX and 109 trades in VIX 02/25/21 Overnight activity included 1020 trades in SPX and 33 trades in VIX 02/24/21 Overnight activity included 2039 trades in SPX and 24 trades in VIX 02/23/21 Overnight activity included 1895 trades in SPX and 55 trades in VIX JNJ Johnson & Johnson $158.52 / -4.28 (-2.63%) 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th 09/23/20 Unusually active option classes on open September 23rd SPY SPX SPY SPDR S&P 500 ETF Trust $380.35 / -2.04 (-0.53%) 14:39 Today On The Fly: ETF fund flow highlights 08:22 Today SPDR S&P 500 ETF Trust: Pivot points 02/25/21 SPDR S&P 500 ETF Trust: Pivot points SPX S&P 500 $0.00 / + (+0.00%) 15:52 Today On The Fly: Weekly technical notes for S&P 500 02/19/21 On The Fly: Weekly technical notes for S&P 500 02/12/21 On The Fly: Weekly technical notes for S&P 500 02/05/21 On The Fly: Weekly technical notes for S&P 500
Hot Stocks	United Airlines to settle Postal Service probe for $49M » 17:06 02/26/21 02/26 17:06 02/26/21 17:06 UAL United Airlines $52.68 / +0.91 (+1.76%) United Airlines has… United Airlines has agreed to pay over $49M to resolve criminal charges and civil claims relating to fraud on postal service contracts for transportation of international mail. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UAL United Airlines $52.68 / +0.91 (+1.76%) 02/21/21 Fly Intel: Top five weekend stock stories 02/19/21 United Airlines plans new nonstop service between Boston Logan, London Heathrow 02/16/21 XpresSpa announces second XpressCheck Covid testing facility at Newark 02/10/21 Urban air mobility company Archer to list on NYSE via Atlas Crest merger UAL United Airlines $52.68 / +0.91 (+1.76%) 02/22/21 Fly Intel: Top five analyst upgrades 02/22/21 Deutsche Bank Deutsche upgrades eight airlines with Covid trending in right direction 02/22/21 Deutsche Bank United Airlines upgraded to Buy from Hold at Deutsche Bank 02/17/21 BofA Mesa Air double-upgraded to Buy from Underperform at BofA UAL United Airlines $52.68 / +0.91 (+1.76%) 01/20/21 United Airlines ended 2020 with $19.7B in available liquidity 01/20/21 United sees Q1 operating revenue down 65%-70%, consensus $4.06B 01/20/21 United Airlines reports Q4 adjusted EPS ($7.00), consensus ($6.60) 01/20/21 Notable companies reporting after market close 22 Apr UAL United Airlines $52.68 / +0.91 (+1.76%) 02/23/21 Pratt & Whitney-made 777 engines already faced new scrutiny, WSJ reports 02/21/21 United to temporarily stop flying some Boeing 777 planes, Reuters reports 02/21/21 United flight sheds debris over Colorado following engine failure, NY Times says UAL United Airlines $52.68 / +0.91 (+1.76%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/22/21 Fly Intel: Pre-market Movers 03/09/21 United Airlines - UAL UAL United Airlines $52.68 / +0.91 (+1.76%) 02/25/21 Unusually active option classes on open February 25th 02/24/21 Early notable gainers among liquid option names on February 24th 02/22/21 Unusually active option classes on open February 22nd 02/19/21 United Continental call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Tomorrow at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting
CRMD
2021-02-28 at 00:00

PDUFA Date for Defencath Government Event
ATNX
2021-02-28 at 00:00

PDUFA Date for Oral Paclitaxel & Encequidar Government Event
2021-02-28 at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting
OOMA
2021-03-01 at 00:00

Ooma - OOMA Conference Calls
DMYD
2021-03-01 at 00:00

dMY Technology II - DMYD Conference Calls
BNPQY ...
2021-03-01 at 00:00

2021 Annual Washington Virtual Conference Conferences

Virtual Conference
AFGL ...
2021-03-01 at 00:00

26th Annual Energy Virtual Summit Conferences

Virtual Summit
QGEN ...
2021-03-01 at 00:00

41st Annual Healthcare Virtual Conference Conferences

Virtual Conference
2021-03-01 at 00:00

AAAAI Virtual Annual Meeting 2021 Conferences

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities Priced at: $4.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair Priced at: $25.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA Priced at: $23.00 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James Priced at: $5.00 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim Priced at: $.75 26.667M Shares RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen Priced at: $21.50 2.795M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc Priced at: $15.00 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FOCS X FOCS Focus Financial Spot Secondary Managers: Goldman Sachs, BofA, KKR & SPC Capital Markets Priced at: $48.00 7M Shares STRM X STRM Streamline Health Spot Secondary Managers: Craig-Hallum Priced at: $1.60 8.75M Shares
Fri	IBERU X IBERU Ibere Pharmaceuticals IPO Managers: Raymond James Priced at: $10.00 12M Shares

Mon	No deals
Tues	No deals
Wed	APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Xylem partners with Americares for COVID-19 response, global health network

TODAY'S FREE FLY STORIES

Get Full Fly Access